'Complaint Against Hec Pharm Co., Ltd., Hec Pharm Usa ( Filing Fee $ 400 Receipt Number 0313-14322511.), Filed By Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma Gmbh & Co. Kg, Boehringer Ingelheim Corporation, Boehringer Ingelheim International Gmbh. (attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Civil Cover Sheet, # 5 Designation Form, # 6 Case Management Track Form, # 7 Report On The Filing Or Determination Of An Action Regarding A Patent Or Trademark)(pizzi, Peter)'
'Disclosure Statement Form Pursuant To Frcp 7.1 By Boehringer Ingelheim Corporation, Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co. Kg, Boehringer Ingelheim Pharmaceuticals Inc..(pizzi, Peter)'
Case number 2:20-cv-02545 was filed in the U.S. District Court for the Eastern District of Pennsylvania on May 29.